Clinico-pathologic features and outcome of Japanese patients with peripheral T-cell lymphomas

Hematological Oncology

Volumn 26, Issue 3, 2008, Pages 152-158

  Niitsu, Nozomi ^a,b   Okamoto, Masataka ^b   Nakamine, Hirokazu ^b   Aoki, Sadao ^b   Motomura, Shigeki ^b   Hirano, Masami ^b  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b The Adult Lymphoma Treatment Study Group: ALTSG ^*  (Japan)

Author keywords

Anaplastic large cell lymphoma; Angioimmunoblastic T cell lymphoma; CyclOBEAP regimen; Peripheral T cell lymphoma; Prognostic index of T cell lymphoma

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; PREDNISONE; VINCRISTINE; ANTINEOPLASTIC AGENT;

ADULT; AGE DISTRIBUTION; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; ANGIOIMMUNOBLASTIC T CELL LYMPHOMA; ARTICLE; BONE MARROW DISEASE; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; DRUG MEGADOSE; DRUG RESPONSE; FEMALE; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; JAPANESE; LARGE CELL LYMPHOMA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL LYMPHOMA; OVERALL SURVIVAL; PERIPHERAL T CELL LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; SURVIVAL TIME; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; HUMANS; LYMPHOMA, T-CELL, PERIPHERAL; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS;

EID: 54049092965     PISSN: 02780232     EISSN: 10991069     Source Type: Journal    
DOI: 10.1002/hon.853     Document Type: Article

References (15)

1. The non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group Classification of non-Hodgkin's lymphoma. Blood 1997; 89: 3909-3918.
2. Gisselbrecht C, Gaulard P, Lepage E, et al. Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d'Etudes des Lymphomes de l'Adulte (GELA). Blood 1998; 92: 76-82.
3. Ascani S, Zinzani PL, Gherlinzoni F, et al. Peripheral T-cell lymphomas. Clinico-pathologic study of 168 cases diagnosed according to the R.E.A.L. Classification. Ann Oncol 1997; 8: 583-592.
4. Rudiger T, Weisenburger DD, Anderson JR, et al. Non-Hodgkin's Lymphoma Classification Project. Peripheral T-cell lymphoma. (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project. Ann Oncol 2002; 13: 140-149.
5. Corradini P, Tarella C, Zallio F, et al. Long-term follow-up of patients with peripheral T-cell lymphornas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation. Leukemia 2006; 20: 1533-1538.
6. Rodriguez J, Conde E, Gutierrez A, et al. On behalf of the 'Grupo Espanol de Linfornas/Trasplante Autologo de Medula Osea' (GEL-TAMO). Frontline autologous stem cell transplantation in high-risk peripheral T-cell lymphoma: a prospective study from the Gel-Tamo Study Group. Eur J Haematol 2007; 79: 32-38.
7. Shipp MA. International non-Hodgkin's lymphoma prognostic factors project: a predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 1993; 329: 987-994.
8. Gallamini A, Stelitano C, Calvi R, et al. Intergruppo Italiano Linforni. Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study. Blood 2004; 103: 2474-2479.
9. Niitsu N, Okamoto M, Aoki S, et al. Multicenter phase II study of the CyclOBEAP (CHOP-like + etoposide and bleomycin) regimen for patients with poor-prognosis aggressive lymphoma. Ann Haematol 2006; 85; 374-380.
10. Jaffe ES, Harris NL, Stein H, Vardiman JW. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. International Agency for Research on Cancer: Lyon, France, 2001.
11. Lymphoma. Study Group of Japanese Pathologists. The World Health Organization classification of malignant lymphomas in Japan: incidence of recently recognization entities. Pathol Int 2000; 50: 696-702.
12. Sonnen R, Schmidt WP, Muller-Hermelink HK, Schmitz N. The international prognostic index determines the outcome of patients with nodal mature T-cell lymphomas. Br J Haematol 2005; 129: 366-372.
13. Hotta T. Treatment of T-cell lymphoma. Hematology 2005; 10 (Suppl 1): 193-196.
14. Pellatt J, Sweetenham J, Pickering RM, Brown L, Wilkins B. A single-centre study of treatment outcomes and survival in 120 patients with peripheral T-cell non-Hodgkin's lymphoma. Ann Hematol 2002; 81: 267-272.
15. Ansell SM, Habermann TM, Kurtin PJ, et al. Predictive capacity of the International Prognostic Factor Index in patients with peripheral T-cell lymphoma. J Clin Oncol 1997; 15: 2296-2301.